Member access

4-Traders Homepage  >  Shares  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

Delayed Quote. Delayed TEL AVIV STOCK EXCHANGE - 03/30 10:24:17 am
24740 ILa   -0.08%
04:58pDJADR Shares End Higher; Carnival Shares Rise
04:40p Stocks rally on merger activity; dollar gains
04:40p Stocks rally on merger activity; dollar gains
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Illumina: Teva Pharmaceutical Exclusive Distributor of Verifi Test in Israel

07/01/2013 | 07:27am US/Eastern
   By Melodie Warner 
 

Illumina Inc. (>> Illumina, Inc.) said Teva Pharmaceutical Industries Ltd. (>> Teva Pharmaceutical Industries Ltd (ADR)) will be the exclusive distributor of the verifi prenatal test in Israel under a five-year agreement.

Financial terms weren't disclosed.

Illumina paid $350 million in February to buy Verinata Health Inc., which gave it access to Verinata's verifi prenatal test, the broadest non-invasive prenatal test currently available for high-risk pregnancies.

The company said the MOR Institute for Medical Data Ltd., through its relationship with Teva, will provide the verifi test to customers of Clalit Health Services who are at high risk of having a fetus with a chromosomal abnormality.

The MOR Institute will also establish a 9,000-patient clinical outcomes registry to collect performance data and will share the data with Verinata.

Illumina said the patient registry developed through this collaboration will be the largest and most extensive of its kind.

Illumina shares closed Friday at $74.84 and were inactive premarket. The stock is up 35% this year.

Write to Melodie Warner at melodie.warner@dowjones.com

Stocks mentioned in the article : Illumina, Inc., Teva Pharmaceutical Industries Ltd (ADR)
React to this article
Latest news on TEVA PHARMACEUTICAL INDUST
04:58pDJADR Shares End Higher; Carnival Shares Rise
04:40p Stocks rally on merger activity; dollar gains
04:40p Stocks rally on merger activity; dollar gains
04:32p Wall St. rebounds from recent losses; deals help
04:23pDJMARKET SNAPSHOT : U.S. Stocks Rally Amid China Easing Hints, Deal News
12:06p Teva to buy U.S. drug developer Auspex Pharma for $3.5 billion
10:35aDJMARKET SNAPSHOT : U.S. Stocks Rally Amid China Easing Hints, Deal News
09:26aDJMARKET SNAPSHOT : U.S. Stocks: Futures Rebound As Bulls Run With Yellen; Chinese..
07:59aDJTeva to Acquire Auspex in $3.2 Billion Deal
07:33a AUSPEX PHARMACEUTICALS : Teva buying Auspex for $3.2 billion
Advertisement
Chart
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | IL0006290147 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF